Literature DB >> 4841837

Screening programs for hypertension.

J Genest, O Kuchel, G Leduc, P Granger, R Boucher, J M Rojo-Ortega, W Nowaczynski.   

Abstract

MAJOR SCREENING PROGRAMS FOR HYPERTENSION ARE NECESSARY FOR THE FOLLOWING REASONS: (a) the 12 to 15% prevalence of hypertension in the North American population; (b) the high proportion of hypertensive patients who are inadequately treated or whose disease is not even recognized; (c) the fact that in too many medical centres hypertension is poorly investigated or considered an insignificant finding; (d) the demonstration by many groups, especially the Framingham study, of hypertension as the major factor in the occurrence of severe cardiovascular disease; and (e) the achievement of a marked decrease in severe cardiovascular complications following adequate treatment. But such screening programs are of little value if unaccompanied by a major educational effort directed not only to the public but also to the medical profession, and a parallel increase in the funding of biomedical research into the basic physiopathological mechanisms of hypertension.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4841837      PMCID: PMC1947612     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  10 in total

1.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

Authors:  W B Kannel; T Gordon; D Offutt
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

2.  Role of blood pressure in the development of congestive heart failure. The Framingham study.

Authors:  W B Kannel; W P Castelli; P M McNamara; P A McKee; M Feinleib
Journal:  N Engl J Med       Date:  1972-10-19       Impact factor: 91.245

3.  Editorial: The hypertension problem. What we can do about it.

Authors:  F A Finnerty
Journal:  Circulation       Date:  1973-10       Impact factor: 29.690

4.  [New concepts on the pathogenesis and treatment of essential arterial hypertension].

Authors:  O Kuchel; G Leduc; J Genest
Journal:  Union Med Can       Date:  1973-04

5.  Current status of hypertension control in an industrial population.

Authors:  J A Schoenberger; J Stamler; R B Shekelle; S Shekelle
Journal:  JAMA       Date:  1972-10-30       Impact factor: 56.272

6.  The natural history of congestive heart failure: the Framingham study.

Authors:  P A McKee; W P Castelli; P M McNamara; W B Kannel
Journal:  N Engl J Med       Date:  1971-12-23       Impact factor: 91.245

7.  Eleven-year follow-up of a patient with malignant hypertension secondary to pyelonephritis and renal insufficiency.

Authors:  T Mawar; J M Rojo-Ortega; J Genest
Journal:  Can Med Assoc J       Date:  1968-07-27       Impact factor: 8.262

8.  Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study.

Authors:  W B Kannel; P A Wolf; J Verter; P M McNamara
Journal:  JAMA       Date:  1970-10-12       Impact factor: 56.272

9.  Evaluation of the initial care of hypertensive patients.

Authors:  E D Frohlich; C Emmott; J E Hammarsten; W M Linehan; D Pollack; A W Horsley
Journal:  JAMA       Date:  1971-11-15       Impact factor: 56.272

10.  Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; M J Schwartz
Journal:  Am J Cardiol       Date:  1971-04       Impact factor: 2.778

  10 in total
  2 in total

1.  The use of multi-media motivation in enhancing compliance of hypertensives discovered at a screening operation.

Authors:  B SerVaas; M H Weinberger
Journal:  Am J Public Health       Date:  1979-04       Impact factor: 9.308

2.  Screening for hypertension: case finding.

Authors:  K V Rudnick
Journal:  Can Fam Physician       Date:  1979-10       Impact factor: 3.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.